18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature
M Gotthardt, A Battmann, H Höffken… - Nuclear medicine …, 2004 - journals.lww.com
Aim To determine the clinical potential of 2-[18 F] fluoro-2-deoxy-D-glucose positron
emission tomography (18 F-FDG PET) in patients with medullary thyroid carcinoma (MTC),
we compared it to computed tomography (CT), and somatostatin receptor scintigraphy
(SRS). Patients and methods Blinded evaluation of PET, CT and SRS images obtained from
26 patients with histologically proven metastatic MTC was done by nuclear medicine and
radiology specialists. Sites of tumour involvement were classified as 'sure'or 'suspicious' …
emission tomography (18 F-FDG PET) in patients with medullary thyroid carcinoma (MTC),
we compared it to computed tomography (CT), and somatostatin receptor scintigraphy
(SRS). Patients and methods Blinded evaluation of PET, CT and SRS images obtained from
26 patients with histologically proven metastatic MTC was done by nuclear medicine and
radiology specialists. Sites of tumour involvement were classified as 'sure'or 'suspicious' …
以上显示的是最相近的搜索结果。 查看全部搜索结果